Hansoh Pharma, a leading innovation-driven pharmaceutical company in the PRC, is committed to improving human health through unremitting innovation, focusing mainly on such areas as anti-tumor, anti-infectives, CNS diseases, metabolic diseases, autoimmune diseases.
After more than 20 years of continuous investment in R&D, Hansoh Pharma has marketed 7 innovative drugs and has over 30 innovative drug programs in different clinical stages with over 50 clinical trials in progress, forming a rich pipeline.
Find the latest and most complete information about Hansoh Pharma!
Hansoh Pharma has always focused on corporate governance, corporate behavior, product safety and quality, access to healthcare, human resource development, environmental protection and community enhancement as the focus and the basis of ESG management, and has been continually committed to improving the medicine availability and the innovative development in fields with unmet clinical needs.
We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!
11月2日上午,市委常委、开发区党工委书记曹卫东调研集团原料药事业部,集团总裁吕爱锋接待了曹书记一行。
曹书记实地考察了原料药生产车间,认真听取了公司原料药事业的发展情况、整体布局和战略规划。豪森自2003年第一个抗肿瘤原料药“酒石酸长春瑞滨”“零缺陷”通过FDA认证后,原料药出口迅速打开局面,覆盖全球大部分国家和地区,成为国内第一批成功实现“走出去”战略的医药企业。